1-9 of 9
Christina Nickenig
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL

Clinical Trials & Observations
Carsten Müller, Niels Murawski, Martin H. J. Wiesen, Gerhard Held, Viola Poeschel, Samira Zeynalova, Michael Wenger, Christina Nickenig, Norma Peter, Eva Lengfelder, Bernd Metzner, Tanja Rixecker, Carsten Zwick, Michael Pfreundschuh, Marcel Reiser
Journal: Blood
Blood (2012) 119 (14): 3276–3284.
https://doi.org/10.1182/blood-2011-09-380949
Published: 2012
Journal Articles

Aggressive Chemotherapy (CHOEP-14) and Rituximab or High-Dose Therapy (MegaCHOEP) and Rituximab for Young, High-Risk Patients with Aggressive B-Cell Lymphoma: Results of the MegaCHOEP Trial of the German High — Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

Norbert Schmitz, Maike Nickelsen, Marita Ziepert, Matthias Haenel, Peter Borchmann, PD, Dr., Andreas Viardot, Christina Nickenig, Martin Bentz, MD, Christian Peschel, MD, Lorenz Trümper, Markus Loeffler, Michael Pfreundschuh, Bertram Glass, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 404.
https://doi.org/10.1182/blood.V114.22.404.404
Published: 2009
Journal Articles

Male Sex Is Associated with Lower Rituximab Trough Serum Levels and Evolves as a Significant Prognostic Factor in Elderly Patients with DLBCL Treated with R-CHOP: Results From 4 Prospective Trials of the German High-Grade Non-Hodgkin-Lymphoma Study Group (DSHNHL).

Michael Pfreundschuh, Niels Murawski, Samira Zeynalova, Viola Poeschel, Marcel Reiser, Anthony D. Ho, Christina Nickenig, Swen Wessendorf, Bernd Metzner, Sandra Grass, Joerg Schubert, Markus Loeffler, Norbert Schmitz
Journal: Blood
Blood (2009) 114 (22): 3715.
https://doi.org/10.1182/blood.V114.22.3715.3715
Published: 2009
Journal Articles

Response Adapted Assignment of the Number of Chemotherapy Cycles for the Treatment of Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Is Not Justified: Results of the RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

Joerg Schubert, Marita Ziepert, Eva Lengfelder, PD, Martin Mohren, PD, Norma Peter, MD, Marcel Reiser, PD, Michael Clemens, Christina Nickenig, MD, Maike deWit, PD, Anthony Ho, Hartmut Eimermacher, MD, Lorenz Truemper, Martin Hoffmann, MD, Roland Mertelsmann, Bernd Metzner, MD, Hans-Guenther Mergenthaler, Ruediger Liersch, MD, Ulrich Duehrsen, Leopold Balleisen, Frank Hartmann, Viola Poeschel, Norbert Schmitz, Markus Loeffler, Michael Pfreundschuh
Journal: Blood
Blood (2007) 110 (11): 788.
https://doi.org/10.1182/blood.V110.11.788.788
Published: 2007
Journal Articles

Serum Levels and Pharmacokinetic of Rituximab in Bi-Weekly R-CHOP in Elderly Patients with DLBCL Treated in the RICOVER-60 Trial.

Marcel Reiser, MD, Michael K. Wenger, MD, Christina Nickenig, MD, N. Peter, MD, Christian Kuhn, MD, Bernd Metzner, MD, Martin Theisohn, MD, Michael Pfreundschuh, MD
Journal: Blood
Blood (2006) 108 (11): 2748.
https://doi.org/10.1182/blood.V108.11.2748.2748
Published: 2006
Journal Articles

Six vs. Eight Cycles of Bi-Weekly CHOP-14 with or without Rituximab for Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Results of the Completed RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

Michael Pfreundschuh, MD, Marita Kloess, Samira Zeynalova, Eva Lengfelder, M.D., Astrid Franke, M.D., Marcel Reiser, M.D., Hjalmar Steinhauer, M.D., Michael Clemens, M.D., Christina Nickenig, M.D., Maike de Wit, M.D., Bernd Metzner, M.D., Manfred Hensel, M.D., Hans-Guenther Mergenthaler, M.D., Ruediger Liersch, M.D., Ulrich Duehrsen, M.D., Leopold Balleisen, M.D., Monika Engelhardt, M.D., Viola Poeschel, M.D., Joerg Schubert, M.D., Lorenz Truemper, M.D., Norbert Schmitz, M.D., Markus Loeffler, M.D.
Journal: Blood
Blood (2006) 108 (11): 205.
https://doi.org/10.1182/blood.V108.11.205.205
Published: 2006
Journal Articles

MCP (Mitoxantrone/Chlorambucil/Prednisolone) Chemotherapy Impairs the Subsequent Collection of Stem Cells in Comparison to CHOP Induction in Patients with Indolent Lymphomas - Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG ).

Christina Nickenig, Martin Dreyling, Eva Hoster, Michael Pfreundschuh, Lorenz Truemper, Marcel Reiser, Hannes Wandt, Michael Unterhalt, Wolfgang Hiddemann
Journal: Blood
Blood (2005) 106 (11): 3331.
https://doi.org/10.1182/blood.V106.11.3331.3331
Published: 2005
Journal Articles

CHOP Improves Response Rates but Not Overall Survival in Follicular and Mantle Cell Lymphoma (MCL)- Results of a Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG ).

Christina Nickenig, MD, Martin H. Dreyling, MD, PhD, Eva Schiegnitz, MSc, Michael Pfreundschuh, MD, PhD, Lorenz H. Truemper, MD, PhD, Marcel Reiser, MD, Hannes Wandt, MD, PhD, Eva Lengfelder, MD, PhD, Wolf-Dieter Ludwig, MD, PhD, Wolfgang E. Berdel, MD, PhD, Bernd Metzner, MD, Georg Hess, MD, Roswitha Forstpointner, MD, Reza Parwaresch, MD, PhD, Joerg Hasford, MD, PhD, Michael Unterhalt, MD, Wolfgang Hiddemann, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 611.
https://doi.org/10.1182/blood.V104.11.611.611
Published: 2004
Journal Articles

Genetic analysis of de novo CD5 + diffuse large B-cell lymphomas suggests an origin from a somatically mutated CD5 + progenitor B cell

Brief Report
Tiemo Katzenberger, Andreas Lohr, Stephan Schwarz, Martin Dreyling, Julia Schoof, Christina Nickenig, Stephan Stilgenbauer, Jörg Kalla, M. Michaela Ott, Hans Konrad Müller-Hermelink, German Ott
Journal: Blood
Blood (2003) 101 (2): 699–702.
https://doi.org/10.1182/blood-2002-06-1726
Published: 2003